YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2

References

• Siegel RL, Miller KD, and Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Scelo G, Larose TL. Epidemiology and risk factors for kidney cancer. J Clin Oncol. 2018;JCO2018791905. DOI:10.1200/JCO.2018.79.1905
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–257.
   PubMed Web of Science ®Google Scholar
• Whelan P. The medical treatment of metastatic renal cell cancer. EAU Update Series. 2003;1(4):237–246.
   Google Scholar
• Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193–205.
   PubMed Web of Science ®Google Scholar
• Prabhu L, Hartley, AV, Martin, M, et al. Role of post-translational modification of the Y box binding protein 1 in human cancers. Genes Dis. 2015;2(3)(:240–246
   Web of Science ®Google Scholar
• Eliseeva IA, Kim ER, Guryanov SG, et al. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc). 2011;76:1402–1433.
   PubMed Web of Science ®Google Scholar
• El-Naggar AM, Veinotte C, Cheng H, et al. Translational activation of HIF1alpha by YB-1 promotes sarcoma metastasis. Cancer Cell. 2015;27(5):682–697.
   PubMed Web of Science ®Google Scholar
• Kuwano M, Shibata T, Watari K, et al. Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer. Cancer Sci. 2019;110(5):1536–1543.
   PubMed Web of Science ®Google Scholar
• Dahl E, En-Nia A, Wiesmann F, et al. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer. 2009;9(410). DOI:10.1186/1471-2407-9-410
   Google Scholar
• Fujii T, Kawahara A, Basaki Y, et al. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers. Cancer Res. 2008;68(1504–1512):1504–1512.
   PubMedGoogle Scholar
• Shibahara K, Sugio, K, Osaki, T, et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res. 2001;7:3151–3155.
   PubMed Web of Science ®Google Scholar
• Gessner C, Woischwill C, Schumacher A, et al. Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer. Eur Respir J. 2004;23(1):14–19.
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Rancso C, Stühmer T, et al. The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma. Blood. 2008;111(7):3714–3722.
   PubMed Web of Science ®Google Scholar
• Oda Y, Sakamoto, A, Shinohara, N, et al. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Clin Cancer Res. 1998;4:2273–2277.
   PubMed Web of Science ®Google Scholar
• Oda Y, Ohishi Y, Saito T, et al. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol. 2003;199(2):251–258.
   PubMed Web of Science ®Google Scholar
• Gimenez-Bonafe P, Fedoruk MN, Whitmore TG, et al. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity. Prostate. 2004;59(3):337–349.
   PubMed Web of Science ®Google Scholar
• Basaki Y, Hosoi F, Oda Y, et al. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene. 2007;26(19):2736–2746.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su, J, Wang, Y, et al. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-kappaB signaling axis. Journal of experimental & clinical cancer research. 2019: 38: 386.
   Google Scholar
• Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol. 2013;14(8):503–517.
   PubMed Web of Science ®Google Scholar
• Larjava H, Plow EF, Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep. 2008;9(12):1203–1208.
   PubMed Web of Science ®Google Scholar
• Rognoni E, Ruppert R, Fassler R. The kindlin family: functions, signaling properties and implications for human disease. J Cell Sci. 2016;129(1):17–27.
   PubMed Web of Science ®Google Scholar
• Yu J, Hu Y, Gao Y, et al. Kindlin-2 regulates hepatic stellate cells activation and liver fibrogenesis. Cell Death Discov. 2018;4(1). DOI:10.1038/s41420-018-0095-9
   Google Scholar
• Tu Y, Wu S, Shi X, et al. Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell. 2003;113(1):37–47.
   PubMed Web of Science ®Google Scholar
• Burridge K. Focal adhesions: a personal perspective on a half century of progress. FEBS J. 2017;284(20):3355–3361.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wu J, Wang Y, et al. Kindlin 2 forms a transcriptional complex with beta-catenin and TCF4 to enhance Wnt signalling. EMBO Rep. 2012;13(8):750–758.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wu J, Guan L, et al. Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int J Cancer. 2013;133(6):1368–1379.
   PubMed Web of Science ®Google Scholar
• Zhang H-F, Zhang K, Liao L-D, et al. miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis. 2014;35(2):292–301.
   PubMed Web of Science ®Google Scholar
• Zhan J, Song J, Wang P, et al. Kindlin-2 induced by TGF-beta signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9. Cancer Lett. 2015;361(1):75–85.
   PubMed Web of Science ®Google Scholar
• An Z, Dobra K, Lock JG, et al. Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration. Int J Cancer. 2010;127(9):1999–2008.
   PubMed Web of Science ®Google Scholar
• Zhan J, Zhu X, Guo Y, et al. Opposite role of Kindlin-1 and Kindlin-2 in lung cancers. PloS One. 2012;7(11):e50313.
   PubMed Web of Science ®Google Scholar
• Talaat S, Somji S, Toni C, et al. Kindlin-2 expression in arsenite- and cadmium-transformed bladder cancer cell lines and in archival specimens of human bladder cancer. Urology. 2011;77(6):e1501–1507.
   Web of Science ®Google Scholar
• Ou Y, Zhao Z, Zhang W, et al. Kindlin-2 interacts with β-catenin and YB-1 to enhance EGFR transcription during glioma progression. Oncotarget. 2016;7(46):74872–74885.
   PubMedGoogle Scholar
• Yan M, Zhang L, Wu Y, et al. Increased expression of kindlin‐2 is correlated with hematogenous metastasis and poor prognosis in patients with clear cell renal cell carcinoma. FEBS Open Bio. 2016;6(7):660–665.
   PubMed Web of Science ®Google Scholar
• Shen Z, Ye Y, KAUTTU T, et al. The novel focal adhesion gene kindlin-2 promotes the invasion of gastric cancer cells mediated by tumor-associated macrophages. Oncol Rep. 2013;29(2):791–797.
   PubMed Web of Science ®Google Scholar
• Shen Z, Ye Y, Dong L, et al. Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancer. Am J Surg. 2012;203(2):222–229.
   PubMed Web of Science ®Google Scholar
• Sossey-Alaoui K, Pluskota E, Bialkowska K, et al. Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1-Mediated Macrophage Infiltration. Cancer Res. 2017;77(18):5129–5141.
   PubMed Web of Science ®Google Scholar
• Guo L, Cui C, Zhang K, et al. Kindlin-2 links mechano-environment to proline synthesis and tumor growth. Nat Commun. 2019;10(1). 10.1038/s41467-019-08772-3
   Google Scholar
• Hu S, Gao Y, Zhou H, et al. New insight into mitochondrial changes in vascular endothelial cells irradiated by gamma ray. Int J Radiat Biol. 2017;93(5):470–476.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Fernandez IA, Rodríguez-Romo L, Hernandez-Barajas D, et al. Adjuvant radiation therapy after radical nephrectomy in patients with localized renal cell carcinoma: a systematic review and meta-analysis. European urology oncology. 2019; 2(4):448–455.
   PubMed Web of Science ®Google Scholar
• Bedke J, Gauler T, Grünwald V, et al. Systemic therapy in metastatic renal cell carcinoma. World J Urol. 2017;35(2):179–188.
   PubMed Web of Science ®Google Scholar
• Stein U, Jürchott K, Walther W, et al. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J Biol Chem. 2001;276(30):28562–28569.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Lasham A, Print CG, Woolley AG, et al. YB-1: oncoprotein, prognostic marker and therapeutic target? Biochem J. 2013;449(1):11–23.
   PubMedGoogle Scholar
• Kohno K, Izumi H, Uchiumi T, et al. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays. 2003;25(7):691–698.
   PubMed Web of Science ®Google Scholar
• Kuwano M, Oda, Y, Izumi, H, et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther. 2004;3:1485–1492.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhao Z, Xu W, et al. Circ-SAR1A promotes renal cell carcinoma progression through miR-382/YBX1 axis. Cancer Manag Res. 2020;12:7353–7361.
   PubMed Web of Science ®Google Scholar
• D’Costa N, Lowerison MR, Raven PA, et al. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma. J Exp Clin Cancer Res. 2020;39(1):33.
   PubMed Web of Science ®Google Scholar
• Yue D, Wang Y, Sun Y et al. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion. Neoplasia. 2017;19:135–144.
   Google Scholar
• Wang Y, Yue D, Xiao M, et al. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis. J Proteome Res. 2015;14(2):804–813.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Geng H, et al. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas. Tumour Biol. 2015;36(9):7159–7166.
   PubMedGoogle Scholar
• Wang Y, Su J, Fu D, et al. The role of YB1 in renal cell carcinoma cell adhesion. Int J Med Sci. 2018;15(12):1304–1311.
   PubMed Web of Science ®Google Scholar
• Liu Y, He, K, Hu, Y, et al. YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor. Sci Rep-Uk. 2017;7(45523). DOI:10.1038/srep45523
   Google Scholar
• Dowling J, Gibbs E, Russell M, et al. Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ Res. 2008;102(4):423–431.
   PubMed Web of Science ®Google Scholar
• Zhao T, Guan L, Yu Y, et al. Kindlin-2 promotes genome instability in breast cancer cells. Cancer Lett. 2013;330(2):208–216.
   PubMed Web of Science ®Google Scholar
• Yan M, Zhang L, Wu Y, et al. Increased expression of kindlin-2 is correlated with hematogenous metastasis and poor prognosis in patients with clear cell renal cell carcinoma. FEBS Open Bio. 2016;6(7):660–665.
   PubMed Web of Science ®Google Scholar
• Liu B, Tan X, Liang J, et al. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells. Sci Rep. 2014;4(1). DOI:10.1038/srep07041
   Google Scholar
• Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981–990.
   PubMed Web of Science ®Google Scholar
• Bratton SB, Cohen GM. Apoptotic death sensor: an organelle’s alter ego? Trends Pharmacol Sci. 2001;22(6):306–315.
   PubMed Web of Science ®Google Scholar
• Li C, Li X, Wu L, et al. Elevated AQP1 expression is associated with unfavorable oncologic outcome in patients with hilar cholangiocarcinoma. Technol Cancer Res Treat. 2017;16(4):421–427.
   PubMed Web of Science ®Google Scholar
• Shen A, Chen H, Chen Y, et al. Pien Tze huang overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal carcinoma cells via suppression of TGF- β pathway. Evid Based Complement Alternat Med. 2014;2014(679436):1–10.
   Google Scholar
• Mallat Z, Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol. 2000;130(5):947–962.
   PubMed Web of Science ®Google Scholar